Experimental drug targets Alzheimer’s

A novel drug reverses some Alzheimer’s-type symptoms in mice, a study shows.

Researchers used mice genetically engineered to accumulate waxy plaques of beta-amyloid protein in their brains, a symptom of Alzheimer’s disease in people. Then, over 8 weeks, the scientists regularly injected some mice with the new drug and gave others inert shots.